Skip to content

Spot analysis of hemoglobin through Pulse CO-Oximeter

Spot Check Noninvasive Hemoglobin (SpHb) Data Collection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046378
Enrollment
2000
Registered
2022-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D571- Sickle-cell disease without crisis Health Condition 2: D569- Thalassemia, unspecified

Interventions

None listed

Sponsors

Masimo Corporation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Weight >3kg

Exclusion criteria

Exclusion criteria: • Skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as psoriasis, eczema, angioma, burns, scar tissue, substantial skin breakdown, nail polish, acrylic nails, infections, abnormalities, etc. • Subjects deemed not suitable for the study at the discretion of the investigator

Design outcomes

Primary

MeasureTime frame
Noninvasive hemoglobin measurement (SpHb) using Masimo Pulse CO-Oximeter device and sensor in a variety subjects, including pediatric subjects, pregnant and non-pregnant adults, healthy individuals and sick patients, with hemoglobin range spanning from 3-18 g/dL .Timepoint: 10 minutes interval

Secondary

MeasureTime frame
Non invasive hemoglobin(SpHb) using Masimo Pulse Co-oximeter before Invasive measurement of Hemoglobin by Blood draw with atleast 15 minutes gap between these two measurements.Timepoint: Spot check analysis at an interval of 15 minutes between invasive and non-invasive measurement.

Countries

India

Contacts

Public ContactDr Gaurij Hood

Shrimad Rajchandra Hospital and Research Centre

gaurij.hood@gmail.com9673879921

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026